How to buy Fisher-and-Paykel Healthcare Corporation shares

Own Fisher-and-Paykel Healthcare Corporation shares in just a few minutes.

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Fisher & Paykel Healthcare Corporation Limited is a medical instruments & supplies business based in Australia. Fisher-and-Paykel Healthcare Corporation shares (FPH) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Fisher-and-Paykel Healthcare Corporation has a trailing 12-month revenue of around $2 billion. If you're looking to buy shares, check out the steps below.

How to buy shares in Fisher-and-Paykel Healthcare Corporation

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Fisher-and-Paykel Healthcare Corporation. Find the share by name or ticker symbol: FPH. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Fisher-and-Paykel Healthcare Corporation reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Fisher-and-Paykel Healthcare Corporation. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Fisher-and-Paykel Healthcare Corporation share price

Use our graph to track the performance of FPH stocks over time.

Fisher-and-Paykel Healthcare Corporation shares at a glance

Information last updated 2021-06-18.
52-week range$25.25 - $34.7585
50-day moving average $29.8536
200-day moving average $30.0708
Target price$11.39
PE ratio 34.2124
Dividend yield $0.38 (1.32%)
Earnings per share (TTM) $0.838

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Name Product Standard brokerage fee Inactivity fee Markets
Superhero share trading
AUD $5
ASX shares, ETFs
Pay zero brokerage on all Australian ETFs.
Trade ASX stocks with a flat $5 commission fee and a low minimum investment of just $100.
ThinkMarkets Share Trading
AUD $8
ASX shares, ETFs
Limited offer: Get 5 free ASX trades when you open a new account with ThinkMarkets before June 30, 2021 (T&Cs apply).
Buy and sell CHESS sponsored ASX shares with $0 brokerage on your first 5 trades. Only $8 flat fee brokerage thereafter, plus enjoy free live stock price data on an easy to use mobile app.
Bell Direct Share Trading
AUD $15
ASX shares, mFunds, ETFs
⭐ Finder Exclusive: Get 5 free stock trades and unlimited ETF trades until July 31, 2021 when you join Bell Direct.
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
IG Share Trading
Finder Award
IG Share Trading
AUD $8 or 0.1%
$50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
AUD $6.99
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Acess 19,000+ stocks on 37 exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Stockbroking
AUD $11 or 0.1%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.

Compare up to 4 providers

Is it a good time to buy Fisher-and-Paykel Healthcare Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Fisher-and-Paykel Healthcare Corporation price performance over time

Historical closes compared with the last close of A$27.6

1 week (2021-06-11) -0.61%
1 month (2021-05-21) -11.60%
3 months (2021-03-19) -2.78%
6 months (2020-12-21) -10.62%
1 year (2020-06-19) 2.68%
2 years (2019-06-21) 91.80%
3 years (2018-06-21) 95.19%
5 years (2016-06-21) 179.35%

Is Fisher-and-Paykel Healthcare Corporation under- or over-valued?

Valuing Fisher-and-Paykel Healthcare Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fisher-and-Paykel Healthcare Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Fisher-and-Paykel Healthcare Corporation's P/E ratio

Fisher-and-Paykel Healthcare Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Fisher-and-Paykel Healthcare Corporation shares trade at around 34x recent earnings.

That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Fisher-and-Paykel Healthcare Corporation's PEG ratio

Fisher-and-Paykel Healthcare Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.4677. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fisher-and-Paykel Healthcare Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Fisher-and-Paykel Healthcare Corporation's EBITDA

Fisher-and-Paykel Healthcare Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $781.3 million.

The EBITDA is a measure of a Fisher-and-Paykel Healthcare Corporation's overall financial performance and is widely used to measure a its profitability.

Fisher-and-Paykel Healthcare Corporation financials

Revenue TTM $2 billion
Operating margin TTM 36.13%
Gross profit TTM $1.2 billion
Return on assets TTM 25.37%
Return on equity TTM 42.03%
Profit margin 26.59%
Book value 2.639
Market capitalisation $16.5 billion

TTM: trailing 12 months

Fisher-and-Paykel Healthcare Corporation share dividends


Dividend payout ratio: 34.87% of net profits

Recently Fisher-and-Paykel Healthcare Corporation has paid out, on average, around 34.87% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.26% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Fisher-and-Paykel Healthcare Corporation shareholders could enjoy a 1.26% return on their shares, in the form of dividend payments. In Fisher-and-Paykel Healthcare Corporation's case, that would currently equate to about A$0.38 per share.

While Fisher-and-Paykel Healthcare Corporation's payout ratio might seem fairly standard, it's worth remembering that Fisher-and-Paykel Healthcare Corporation may be investing much of the rest of its net profits in future growth.

The latest dividend was paid out to all shareholders who bought their shares by 23 June 2021 (the "ex-dividend date").

Have Fisher-and-Paykel Healthcare Corporation's shares ever split?

Fisher-and-Paykel Healthcare Corporation's shares were split on a 5:1 basis on 26 September 2004. So if you had owned 1 share the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Fisher-and-Paykel Healthcare Corporation shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for Fisher-and-Paykel Healthcare Corporation shares which in turn could have impacted Fisher-and-Paykel Healthcare Corporation's share price.

Fisher-and-Paykel Healthcare Corporation share price volatility

Over the last 12 months, Fisher-and-Paykel Healthcare Corporation's shares have ranged in value from as little as $25.25 up to $34.7585. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Fisher-and-Paykel Healthcare Corporation's is -0.157. This would suggest that Fisher-and-Paykel Healthcare Corporation's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Fisher-and-Paykel Healthcare Corporation has bucked the trend.

Fisher-and-Paykel Healthcare Corporation overview

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. It also provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. In addition, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site
Not sure what platform to go with?
Take this quick quiz to find the right share trading platform